Article Figures & Data
Figures
- FIGURE 1.
Scatter plots of correlation between NLR and SUVBSAg (A), simplified kinetic method (B), and Patlak graphical analysis (C).
Tables
- TABLE 1
Comparison of Glucose Consumption Measurements with Analytic Methods by Regression Analysis with Those of NLR
Method r2 Slope SE Intercept SE T/N 40–60 min 0.712 58.10 7.25 1.471 1.231 T/N 50–60 min 0.701 61.91 7.94 1.592 1.348 SUVW, 40–60 min 0.898 30.54 1.94 0.768 0.332 SUVWg, 40–60 min 0.910 34.77 2.06 0.009 0.356 SUVLBM, 40–60 min 0.845 27.01 2.20 0.987 0.376 SUVLBMg, 40–60 min 0.925 30.42 1.63 0.326 0.279 SUVBSA, 40–60 min 0.914 765.5 44.38 22.54 7.60 SUVBSAg, 40–60 min 0.966* 865.4 30.96 3.813 5.30 SUVW, 50–60 min 0.898 32.11 2.04 0.753 0.349 SUVWg, 50–60 min 0.908 36.53 2.19 −0.039 0.376 SUVLBM, 50–60 min 0.846 28.40 2.29 0.986 0.392 SUVLBMg, 50–60 min 0.925 31.97 1.72 0.296 0.294 SUVBSA, 50–60 min 0.914 804.8 46.67 22.30 7.99 SUVBSAg, 50–60 min 0.964* 909.4 33.31 2.767 5.71 Net influx constant (W) 0.910 1.027 0.061 0 0.011 Net influx constant (BSA) 0.966* 0.871 0.031 0.004 0.005 SKM 40–60 min† 0.974* 0.893 0.028 0.007 0.005 SKM 50–60 min† 0.972* 0.891 0.028 0.006 0.005 Patlak (10–60 min) MRglu 0.984* 0.931 0.022 0.004 0.004 Patlak (10–45 min) MRglu 0.982* 0.941 0.023 0.004 0.004 Patlak (10–30 min) MRglu 0.951* 0.959 0.042 0.009 0.007 Patlak (20–60 min) MRglu 0.972* 0.921 0.029 0.008 0.005 Patlak (30–60 min) MRglu 0.968* 0.893 0.031 0.013 0.005 TLE (0.5) MRglu‡ 0.638 83.31 11.83 −4.095 2.023 TLE (0.5) MRglu§ 0.619 0.318 0.047 0.041 0.008 TLE (0.6) MRglu‡ 0.658 75.84 10.33 −4.263 1.769 TLE (0.6) MRglu§ 0.679 0.370 0.048 0.048 0.008 TLE (0.7) MRglu‡ 0.676 67.04 8.77 −4.402 1.502 TLE (0.7) MRglu§ 0.699 0.451 0.056 0.053 0.009 TLE (0.8) MRglu‡ 0.679 53.71 6.97 −4.168 1.194 TLE (0.8) MRglu§ 0.835 0.577 0.049 0.062 0.008 TLE (0.9) MRglu‡ 0.536 29.27 5.14 −2.800 0.881 TLE (0.9) MRglu§ 0.815 0.739 0.080 0.075 0.016 2-ROI, 6-parameter model 0.419 2.406 0.556 −0.073 0.094 ↵* r2 > 0.95.
↵† Simplified kinetic method described by Hunter et al. (17).
↵‡ Total lesion evaluation method described by Wu et al. (14).
↵§ Correlative imaging method described by Zasadny et al. (15).
W = body weight; Wg = W plasma glucose; LBM = lean body mass; LBMg = LBM plasma glucose; BSA = body surface area; BSAg = BSA plasma glucose; MRglc = metabolic rate of glucose.
In this issue
Jump to section
Related Articles
Cited By...
- Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer
- Repeatability of SUV in Oncologic 18F-FDG PET
- Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials
- Repeatability of Quantitative FDG-PET/CT and Contrast-Enhanced CT in Recurrent Ovarian Carcinoma: Test-Retest Measurements for Tumor FDG Uptake, Diameter, and Volume
- Variability of Total Lesion Glycolysis by 18F-FDG-Positive Tissue Thresholding in Lung Cancer
- Repeatability of 18F-FDG Uptake Measurements in Tumors: A Metaanalysis
- Need for Standardization of 18F-FDG PET/CT for Treatment Response Assessments
- Monitoring Response to Antiangiogenic Therapy in Non-Small Cell Lung Cancer Using Imaging Markers Derived from PET and Dynamic Contrast-Enhanced MRI
- Repeatability of 18F-FDG PET in a Multicenter Phase I Study of Patients with Advanced Gastrointestinal Malignancies
- Standards for PET Image Acquisition and Quantitative Data Analysis
- Reproducibility of Tumor Perfusion Measurements Using 15O-Labeled Water and PET
- Comparison of Tumor Volumes Derived from Glucose Metabolic Rate Maps and SUV Maps in Dynamic 18F-FDG PET
- Long-Term Precision of 18F-Fluoride PET Skeletal Kinetic Studies in the Assessment of Bone Metabolism
- Chemotherapy Response Evaluation with 18F-FDG PET in Patients with Non-Small Cell Lung Cancer
- Dynamic and Static Approaches to Quantifying 18F-FDG Uptake for Measuring Cancer Response to Therapy, Including the Effect of Granulocyte CSF
- Sequential Positron Emission Tomography Using [18F]Fluorodeoxyglucose for Monitoring Response to Chemotherapy in Metastatic Breast Cancer.
- Prognostic Relevance of Response Evaluation Using [18F]-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Patients With Locally Advanced Non-Small-Cell Lung Cancer
- 18F-Fluoride PET for Monitoring Therapeutic Response in Paget's Disease of Bone
- Effects of Noise, Image Resolution, and ROI Definition on the Accuracy of Standard Uptake Values: A Simulation Study
- Within-Patient Variability of 18F-FDG: Standardized Uptake Values in Normal Tissues
- Prediction of Response to Preoperative Chemotherapy in Gastric Carcinoma by Metabolic Imaging: Results of a Prospective Trial
- Imaging Proliferation in Lung Tumors with PET: 18F-FLT Versus 18F-FDG
- Positron Emission Tomography in Non-Small-Cell Lung Cancer: Prediction of Response to Chemotherapy by Quantitative Assessment of Glucose Use